AI and the future of pharma with Bob Bradway, CEO of Amgen @bainandcompany
AI and the future of pharma with Bob Bradway, CEO of Amgen  @bainandcompany
Uploaded June 2026 | Updated September 2026, 1 hour ago
How do you get ahead, when all of your competitors have access to the same revolutionary AI tools? According to Bob Bradway, CEO of Amgen, it’s by getting a head start.

Bob Bradway started his digital transformation at Amgen when he took the helm 14 years ago. Today, driven by AI, they’re transforming every step of their business with forward-thinking and discretion. And looking ahead at agentic innovations, he’s getting his hands on the keyboard to lead from the top.

Hear how AI is transforming not just how new drugs are developed, but how the people behind the drugs work and think.

Join the Conversation: To learn more about the Winning with AI podcast check out (bain.com/insights/topics/winning-with-ai-podcast/) or hit the link for additional AI Insights (bain.com/insights/topics/ai/)

Bain & Company LinkedIn | / bain-and-company
Bain & Company X | https://x.com/BainandCompany
AI and the future of pharma with Bob Bradway, CEO of AmgenThrive At Bain | JulieMaintaining Relevance Amid UncertaintyOlam CEO: Don’t mistake profits for value creationRethinking Transformation: Lawrence Lam on Leading Change at PrudentialBe More at Bain | TiiramThe Net Promoter System℠: How to Do More With the Net Promoter Score℠Be More at Bain | NicolePrivate Equity Spotlight 2024 with Roberto Fiorello - Chapter 1A Day in Life at Bain AmsterdamStay Relevant, Spark Energy: Pedro Arnt, CEO dLocalProduct Management & Innovation at Bain | Fabian
Bain & Company |

AI and the future of pharma with Bob Bradway, CEO of Amgen

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER